-
During November 2023, the CIDG contributed to one new Cochrane protocol and one updated review in Issue 11, 2023 of the Cochrane Database of Systematic Reviews.New protocolToriro R, Nevin W, Kuehn R, Ryan H, Beeching N, Fletcher T, Burns D. Antibiotic treatment to reduce the duration and severity of travellers’ diarrhoea. Cochrane Database of...
November 30 2023
-
Is the combination of nirmatrelvir plus ritonavir effective for treating or preventing COVID‐19?Key messagesNirmatrelvir/ritonavir (Paxlovid) is evaluated for the treatment of coronavirus disease 2019 (COVID‐19).Nirmatrelvir/ritonavir may lead to fewer deaths and improve patient condition, as assessed by need for hospitalization or death within 28...
November 30 2023
-
Once the mainstay of child health clinics in low- and middle-income countries (LMICs), a new Cochrane Review of growth monitoring and promotion (GMP) shows the evidence to support its use is limited and uncertain. The authors looked at GMP from all angles: to identify and address growth faltering, inadequate infant and child feeding practices, and...
November 24 2023
-
The annual Cochrane Colloquium brings people together from around the world to discuss research into important global health questions and promote evidence-informed health care. The 2023 theme, ‘Forward together for trusted evidence’, explored the challenges for the future around trustworthiness of healthcare data and information whilst also...
November 7 2023
-
What is growth monitoring and promotion?Many children under five years of age who live in low‐ and middle‐income countries are not receiving adequate nutrition. This can lead to increased illnesses, impaired mental development (which diminishes school and work performance later in life) and death. Growth monitoring and promotion (GMP) is a complex...
November 1 2023
-
During October 2023, the CIDG contributed to one new Cochrane Review in Issue 10, 2023 of the Cochrane Database of Systematic Reviews.New reviewTaylor M, Tapkigen J, Ali I, Liu Q, Long Q, Nabwera H. The impact of growth monitoring and promotion on health indicators in children under five years of age in low‐ and middle‐income countries....
October 31 2023
-
During September 2023, the CIDG published one new Cochrane Protocol in Issue 9, 2023 of the Cochrane Database of Systematic Reviews.New Cochrane ProtocolInbaraj LR, Daniel J, Sathya Narayanan MK, Srinivasalu VA, Bhaskar A, Rajendran P, Daniel BD, Epsibha T, Scandrett K, Rose W, Takwoingi Y. TB‐LAMP (loop‐mediated isothermal amplification) for...
September 28 2023
-
During August 2023, the CIDG published one new Cochrane Review in Issue 8, 2023 of the Cochrane Database of Systematic Reviews.New Cochrane ReviewGabaldón FIguerira JC, Wagah MG, Adipo LB, Wanjiku C, Maia MF. Topical repellents for malaria prevention. Cochrane Database of Systematic Reviews 2023, Issue 8. Art. No.: CDO15422. DOI:10.1002/...
August 30 2023
-
What are the benefits and risks of using topical insect repellents to prevent malaria?Key messages• Topical repellents may slightly reduce the incidence and prevalence of malaria caused by Plasmodium falciparum.• These changes seem to be particularly important in high‐risk populations, specifically in refugees living in camps where there are...
August 22 2023
-
During July 2023, the CIDG published one new Cochrane Review in Issue 7, 2023 of the Cochrane Database of Systematic Reviews.New Cochrane ReviewFox T, Hunt BJ, Ariens RAS, Towers GJ, Lever R, Garner P, Kuehn R. Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post‐COVID‐19 condition. Cochrane Database of...
August 2 2023
During November 2023, the CIDG contributed to one new Cochrane protocol and one updated review in Issue 11, 2023 of the Cochrane Database of Systematic Reviews.New protocolToriro R, Nevin W, Kuehn R, Ryan H, Beeching N, Fletcher T, Burns D. Antibiotic treatment to reduce the duration and severity of travellers’ diarrhoea. Cochrane Database of...November 30 2023
Is the combination of nirmatrelvir plus ritonavir effective for treating or preventing COVID‐19?Key messagesNirmatrelvir/ritonavir (Paxlovid) is evaluated for the treatment of coronavirus disease 2019 (COVID‐19).Nirmatrelvir/ritonavir may lead to fewer deaths and improve patient condition, as assessed by need for hospitalization or death within 28...November 30 2023
Once the mainstay of child health clinics in low- and middle-income countries (LMICs), a new Cochrane Review of growth monitoring and promotion (GMP) shows the evidence to support its use is limited and uncertain. The authors looked at GMP from all angles: to identify and address growth faltering, inadequate infant and child feeding practices, and...November 24 2023
The annual Cochrane Colloquium brings people together from around the world to discuss research into important global health questions and promote evidence-informed health care. The 2023 theme, ‘Forward together for trusted evidence’, explored the challenges for the future around trustworthiness of healthcare data and information whilst also...November 7 2023
What is growth monitoring and promotion?Many children under five years of age who live in low‐ and middle‐income countries are not receiving adequate nutrition. This can lead to increased illnesses, impaired mental development (which diminishes school and work performance later in life) and death. Growth monitoring and promotion (GMP) is a complex...November 1 2023
During October 2023, the CIDG contributed to one new Cochrane Review in Issue 10, 2023 of the Cochrane Database of Systematic Reviews.New reviewTaylor M, Tapkigen J, Ali I, Liu Q, Long Q, Nabwera H. The impact of growth monitoring and promotion on health indicators in children under five years of age in low‐ and middle‐income countries....October 31 2023
During September 2023, the CIDG published one new Cochrane Protocol in Issue 9, 2023 of the Cochrane Database of Systematic Reviews.New Cochrane ProtocolInbaraj LR, Daniel J, Sathya Narayanan MK, Srinivasalu VA, Bhaskar A, Rajendran P, Daniel BD, Epsibha T, Scandrett K, Rose W, Takwoingi Y. TB‐LAMP (loop‐mediated isothermal amplification) for...September 28 2023
What are the benefits and risks of using topical insect repellents to prevent malaria?Key messages• Topical repellents may slightly reduce the incidence and prevalence of malaria caused by Plasmodium falciparum.• These changes seem to be particularly important in high‐risk populations, specifically in refugees living in camps where there are...August 22 2023
During July 2023, the CIDG published one new Cochrane Review in Issue 7, 2023 of the Cochrane Database of Systematic Reviews.New Cochrane ReviewFox T, Hunt BJ, Ariens RAS, Towers GJ, Lever R, Garner P, Kuehn R. Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post‐COVID‐19 condition. Cochrane Database of...August 2 2023